ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

Cochrane2026IaEN

Cochrane Review: Ginkgo biloba for cognitive impairment and dementia

Zusammenfassung

Ginkgo biloba bei kognitiver Beeinträchtigung und Demenz - Wieland, LS - 2026 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013661.pub2/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013661.pub2/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you

Kerninformationen

views](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Dementia is a neurocognitive disorder that interferes with cognition and independent functioning. Common dementia subtypes include Alzhe...
gically plausible. ### Objectives To assess the benefits and harms of _Ginkgo biloba_ for the treatment of people with cognitive impairment or dementia. ### Search methods We searched the Cochrane Dementia and Cognitive Improvement Group's register, MEDLINE, Embase, four other databases, and two...
of bias. Key outcomes were global clinical status, global cognitive function, activities of daily living (ADLs), adverse events (AEs), and serious adverse events (SAEs) at six months. When clinically appropriate, we pooled data using a random‐effects model and expressed treatment effects as mean di...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien